E-viri
PDF
Recenzirano
Odprti dostop
-
Mack, Michael J; Leon, Martin B; Thourani, Vinod H; Makkar, Raj; Kodali, Susheel K; Russo, Mark; Kapadia, Samir R; Malaisrie, S. Chris; Cohen, David J; Pibarot, Philippe; Leipsic, Jonathon; Hahn, Rebecca T; Blanke, Philipp; Williams, Mathew R; McCabe, James M; Brown, David L; Babaliaros, Vasilis; Goldman, Scott; Szeto, Wilson Y; Genereux, Philippe; Pershad, Ashish; Pocock, Stuart J; Alu, Maria C; Webb, John G; Smith, Craig R
The New England journal of medicine, 05/2019, Letnik: 380, Številka: 18Journal Article
In a randomized trial, 1000 patients with severe aortic stenosis who were at low risk for death with surgery were assigned to undergo transcatheter aortic-valve replacement with a balloon-expandable valve or surgical aortic-valve replacement. At 1 year, the rate of death, stroke, or rehospitalization was significantly lower in the TAVR group.
